Marker Therapeutics, Inc. (MRKR)
Q3 2019 Earnings Conference Call
November 12, 2019 5:00 PM ET
Company Participants
Tony Kim – Chief Financial Officer
Peter Hoang – President and Chief Executive Officer
Mythili Koneru – Senior Vice President-Clinical Development
Conference Call Participants
Jackson Harvey – Nomura/Instinet
Ted Tenthoff – Piper Jaffray
Matt Biegler – Oppenheimer & Company
Tony Butler – Roth Capital
Yun Zhong – Janney
Presentation
Operator
Greetings, and welcome to the Marker Therapeutics’ Third Quarter 2019 Operating and Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer